In the early Drosophila embryo, asymmetric distribution of transcription factors, established as a consequence of translational control of their maternally derived mRNAs, initiates pattern formation [1] [2] [3] [4] . For instance, translation of the uniformly distributed maternal hunchback (hb) mRNA is inhibited at the posterior to form an anterior-to-posterior protein concentration gradient along the longitudinal axis [5, 6] . Inhibition of hb mRNA translation requires an mRNP complex (the NRE complex), which consists of Nanos (Nos), Pumilio (Pum), and Brain tumor (Brat) proteins, and the Nos responsive element (NRE) present in the 3 0 UTR of hb mRNA [7] [8] [9] . The identity of the mRNA 5 0 effector protein that is responsible for this translational inhibition remained elusive. Here we show that d4EHP, a cap binding protein that represses caudal (cad) mRNA translation [10] , also inhibits hb mRNA translation by interacting simultaneously with the mRNA 5 0 cap structure (m 7 GpppN, where N is any nucleotide) [11] and Brat. Thus, by regulating Cad and Hb expression, d4EHP plays a key role in establishing anteriorposterior axis polarity in the Drosophila embryo.
In the early Drosophila embryo, asymmetric distribution of transcription factors, established as a consequence of translational control of their maternally derived mRNAs, initiates pattern formation [1] [2] [3] [4] . For instance, translation of the uniformly distributed maternal hunchback (hb) mRNA is inhibited at the posterior to form an anterior-to-posterior protein concentration gradient along the longitudinal axis [5, 6] . Inhibition of hb mRNA translation requires an mRNP complex (the NRE complex), which consists of Nanos (Nos), Pumilio (Pum), and Brain tumor (Brat) proteins, and the Nos responsive element (NRE) present in the 3 0 UTR of hb mRNA [7] [8] [9] . The identity of the mRNA 5 0 effector protein that is responsible for this translational inhibition remained elusive. Here we show that d4EHP, a cap binding protein that represses caudal (cad) mRNA translation [10] , also inhibits hb mRNA translation by interacting simultaneously with the mRNA 5 0 cap structure (m 7 GpppN, where N is any nucleotide) [11] and Brat. Thus, by regulating Cad and Hb expression, d4EHP plays a key role in establishing anteriorposterior axis polarity in the Drosophila embryo.
Results and Discussion
Transcription is globally repressed in the rapidly dividing nuclei of early Drosophila embryos, and therefore gene expression is largely regulated by translational control of maternally provided mRNAs [1] . Translation is often regulated at initiation, which occurs in multiple steps starting with the recruitment of the 40S ribosomal subunit to the 5 0 end of an mRNA and resulting in the correct positioning of the 80S ribosome at the initiation codon [12, 13] . Recognition of the cap structure by eIF4F (composed of three subunits, eIF4E, eIF4A, and eIF4G) is an integral part of this process. Moreover, eIF4G interacts both with eIF4E and the poly(A) binding protein (PABP), thus circularizing the mRNA, which in turn is believed to promote reinitiation [2, 14, 15] . Consistent with their importance, eIF4E and PABP have emerged as major targets of translational regulatory mechanisms mediated by such modulator proteins as 4E-BPs and Paip2 [15] [16] [17] .
Embryonic development in many metazoans requires the activity of various maternal determinants called morphogens, whose spatial and temporal expression is tightly regulated [1] [2] [3] [4] . In Drosophila, local morphogen concentrations are important for the establishment of polarity and subsequent organization of both the anteroposterior and dorsoventral axes of the embryo. A key morphogen for anteroposterior patterning is the transcription factor Hunchback (Hb); when maternal Hb is allowed to accumulate inappropriately, posterior segmentation is blocked [8, 18, 19] . Two modes of translational control have been proposed for the establishment of the maternal Hb gradient: translational silencing via deadenylation [20] and inhibition at the initiation step in a capdependent manner [9] .
d4EHP, an eIF4E-like cap binding protein that does not interact with deIF4G and d4E-BP, inhibits the translation of cad mRNA by interacting simultaneously with the cap and Bicoid (Bcd) [10] . While many embryos (w41%) produced by females homozygous for the d4EHP CP53 mutation showed anterior patterning defects consistent with mislocalized Cad, some (w7%) also exhibited patterning defects such as missing abdominal segments [10] that cannot be readily explained by ectopic Cad expression. Since inhibition of hb mRNA translation has been linked in one study to the cap structure [9] , and since these additional phenotypes could be consistent with inappropriate regulation of Hb, we investigated the role of d4EHP in Hb expression. Embryos (0-2 hr) from females homozygous for the d4EHP CP53 mutation [10] were collected and immunostained with Hb antibody. DNA was stained with DAPI to highlight the nuclei ( Figures 1A-1E ). For simplicity, embryos will subsequently be referred to by their maternal genotype. To evaluate the extent of the Hb gradient, we measured its signal intensity at 38-50 locations along the anteriorposterior axes of 6-16 embryos of each genotype. We corrected the values for overall signal intensity and then normalized the data for embryo length (EL, anterior pole = 0%, posterior pole = 100%, see Experimental Procedures). The normalized values were plotted and average intensity values were calculated to obtain an average trend (see Experimental Procedures; Figures 1F  and 1G ). We observed that in Ore R embryos, Hb signal intensity drops steeply in the middle of the embryo ( Figure 1A ) and reaches 50% maximum intensity at 48% EL ( Figure 1F ). In d4EHP CP53 embryos, the Hb expression domain extended substantially farther toward the posterior ( Figure 1B ) and signal intensity remained at approximately 50% of the maximum throughout the *Correspondence: paul.lasko@mcgill.ca (P.L.), nahum.sonenberg@ mcgill.ca (N.S.)region between 50% and 75% EL ( Figure 1F ). Normal Hb distribution was restored to d4EHP CP53 mutant embryos by transgene-derived expression of wild-type d4EHP (d4EHP wt , Figures 1C and 1G ), but not by expression of a mutant form of d4EHP (d4EHP W114A ), which is unable to bind the cap structure ( Figures 1D and 1G ). Expression of another form of d4EHP (d4EHP W85F ), which cannot bind Bcd, fully rescued the defective Hb gradient ( Figures 1E and 1G ). The expression levels of the wildtype and mutant d4EHP transgenes are essentially equal [10] . Distributions of Nos, Pum, and Brat were unaffected in d4EHP CP53 mutant embryos ( Figure S1 in the Supplemental Data available online). Taken together, these data demonstrate that d4EHP plays a key role in establishing the posterior boundary of Hb expression in a manner that requires its cap binding activity but not an association with Bcd.
We reasoned that Brat might be a candidate partner protein for d4EHP, since both are relevant for hb regulation. Thus, we investigated whether d4EHP and Brat physically interact in vivo. Extracts prepared from 0 to 2 hr Oregon-R (Ore R ) embryos were treated with RNase and used to examine the interaction between Brat and d4EHP. Western blotting analysis with antibodies against d4EHP [10] and Brat ( Figure S2 ) demonstrates that, while anti-d4EHP coimmunoprecipitated endogenous Brat (Figure 2A ; lane 3), preimmune serum did not (lane 2). To further demonstrate the specificity of this interaction, HA-tagged deIF4EI and the RNA-binding protein La (negative controls) were transfected in HEK293 cells along with FLAG-tagged full-length Brat. While FLAG antibody immunoprecipitated wild-type HA-d4EHP together with FLAG-Brat ( Figure 2B , lane 2), deIF4EI and La failed to coimmunoprecipitate (lanes 1 and 3). Similarly, other RNA-binding proteins such as hnRNP U and HuR, and a d4EHP mutant (W173A), in which a tryptophan residue that is part of the hydrophobic core and thus affects protein folding is replaced, W114A (lane 2), and d4EHP deIF4EI helix 3 (lane 3) were incubated with m 7 GTP-Sepharose, and the eluate was analyzed by western blotting (bottom). (E) d4EHP interacts with the Brat C-terminal NHL domain. FLAG-tagged Brat wild-type or DNHL mutant were transfected in HEK293 cells with HA-tagged d4EHP, and cell extracts were subjected to western blotting (top). Cell extracts were immunoprecipitated with a FLAG antibody and analyzed by western blotting (bottom). (F) Ribbon diagrams of the Brat NHL domain [21] . The positions of select surface residues are indicated. (G) Interaction of Brat mutants with d4EHP. FLAG-tagged wild-type (lane 2) or mutants of the Brat NHL domain (lanes 3-7) were transfected in HEK293 cells together with HA-tagged d4EHP, and cell extracts were subjected to western blotting (top). Cell extracts were immunoprecipitated with a FLAG antibody and eluted proteins were analyzed for the presence of FLAG-Brat and HA-d4EHP by western blotting (bottom). All proteins shown migrated at the positions expected from their molecular mass, as compared with molecular weight markers run on the same gels (data not shown).
also failed to interact with Brat (data not shown), demonstrating that Brat interacts specifically with d4EHP. Since we used a cell transfection system to assay for the d4EHP:Brat interaction, it is possible that other bridging proteins are required for the d4EHP-Brat association.
To identify the Brat-interacting domain of d4EHP, we first mutated a number of individual residues located on its convex dorsal surface and tested for coimmunoprecipitation with Brat. From this work, we were unable to identify a point mutant of d4EHP that abrogated the interaction (data not shown). As an alternative approach, we created chimeric proteins in which different domains of d4EHP were replaced with their counterparts from de-IF4EI, taking advantage of our knowledge that, unlike d4EHP, deIF4EI does not interact with Brat ( Figure 2C , lane 1). We produced three mutant forms of d4EHP, with each one of its three dorsal a helices [21] replaced with that of deIF4EI. We found that while helix 1 and 2 mutants failed to disrupt binding to Brat ( Figure 2C, lanes 3  and 4) , replacement of d4EHP helix 3 (residues 179-194) significantly reduced the interaction with Brat ( Figure 2C , lane 5). Consistent with these observations, a helix 3 is the most divergent between d4EHP and deIF4EI [10] . The overall structure of d4EHP is not affected by the replacement of helix 3 with its deIF4EI counterpart, since the chimeric protein still binds to the cap ( Figure 2D,  lane 3) . Thus, our data demonstrate that Brat interacts with d4EHP on its convex dorsal surface and that this interaction is mediated by the third a helix of d4EHP.
A C-terminal domain of Brat termed the NHL domain is both necessary and sufficient to inhibit hb mRNA translation [7] . The NHL domain contains two large surfaces (defined as top and bottom) that can support proteinprotein interactions [22] . While the top surface of the NHL domain binds to Pum and Nos, the bottom surface does not interact with any known protein [7, 22] . Although the Brat NHL domain contains an amino acid sequence that conforms to the YxxxxxxLF d4EHP binding motif [10] , the d4EHP:Brat interaction does not require this motif, since a Brat deletion mutant that lacks it can still interact with both d4EHP and the d4EHP W85F mutant ( Figure S3 ). This sequence is most probably masked from interaction with d4EHP because it is located in the hydrophobic core of the NHL domain [22] . To determine whether the d4EHP:Brat interaction requires the NHL domain, a Brat mutant that lacks the domain (Brat DNHL) was engineered and used in a coimmunoprecipitation experiment ( Figure 2E ). While wild-type Brat was readily coimmunoprecipitated with d4EHP, the Brat DNHL mutant was not (compare lanes 1 and 2). Thus, we conclude that the NHL domain is the site of d4EHP interaction. To further characterize this interaction, point mutations were designed to replace residues on the two surfaces of the NHL domain ( Figure 2F ), and the mutant proteins were tested for their ability to interact with d4EHP. Mutation of a top surface residue that affects Brat interaction with Pum (G774A; Figure 2G , lane 3) [7] did not affect the d4EHP:Brat interaction. However, when residues on the bottom surface were mutated, the d4EHP:Brat interaction was either significantly reduced (G860D and KE809/810AA; lanes 4 and 5) or abrogated (R837D and K882E; lanes 6 and 7; note that the charge differences caused R837D and K882E mutant proteins to migrate slower in the gel). Importantly, the Brat NHL R837D mutant can assemble into an NRE complex (see below; Figure 3 , lane 4), demonstrating that this mutation specifically affects the d4EHP interaction and not the interactions with Pum and Nos.
Brat inhibits hb mRNA translation by interacting with the NRE complex [7] . Since d4EHP interacts physically with Brat, we asked whether d4EHP can be copurified with the NRE complex in vitro. Incubation of recombinant components of the NRE complex (Brat, Pum, Nos, and NRE) together with HA-tagged d4EHP resulted in the retention of d4EHP on glutathione-Sepharose beads through the GST-Pum RNAB fusion protein (Figure 3 , Samples containing in vitro translated HAtagged d4EHP and purified components of the NRE complex were used to perform an in vitro GST pull-down experiment. Eluted proteins were analyzed for the presence of GST-Pum RNAB, His 6 -Nos C-term, His 6 -Brat NHL domain, and HA-d4EHP by western blotting. All proteins shown migrated at the positions expected from their molecular mass, as compared with molecular weight markers run on the same gels (data not shown).
lane 2). The association of Brat with d4EHP was dependent on the ability of d4EHP to bind to Brat, since addition of Pum/Nos/NRE alone or in combination with the Brat R837D mutant failed to capture it (lanes 3 and 4) . Thus, by interacting with Brat, d4EHP can associate with the NRE complex.
To investigate the biological significance of the d4EHP:Brat interaction, we studied the effects of Brat mutants, which are defective for d4EHP binding, in Drosophila embryos. As previously shown [7] , brat fs1 mutant embryos exhibit a significant expansion of the Hb expression domain toward the posterior (Figures 4A and  4B ) and display severe abdominal segmentation defects (Table 1) . When a brat WT transgene is expressed in the brat fs1 mutant background, normal Hb distribution (Figures 4C and 4D ) and a wild-type segmentation pattern is restored [7] (Table 1) . To investigate whether interaction with d4EHP is essential for the function of Brat in embryonic patterning, we introduced transgenes encoding mutant forms of Brat that affect the d4EHP:Brat interaction (brat R837D and brat K882E ) into the brat fs1 mutant background. Despite being expressed at levels similar to the brat WT transgene (Figure 4I ), these mutant forms fail to fully rescue the normal Hb gradient (Figures 4E-4H ) and, importantly, do not fully rescue the brat fs1 mutant phenotype (Table 1) . Taken together, our data strongly argue that the d4EHP:Brat interaction contributes significantly to hb regulation.
We have demonstrated here that through its interaction with Brat, d4EHP defines and sharpens the posterior boundary of Hb expression. Based on the hypomorphic d4EHP CP53 phenotype, its activity appears most relevant to hb regulation in the region of the embryo from 50% to 75% EL, although it is possible that a null d4EHP allele would have more drastic effects. The d4EHP:Brat interaction is mediated via residues on the bottom surface of the Brat NHL domain ( Figures  2F and 2G) . Thus, as in the model we established for cad [10] , a simultaneous interaction of d4EHP with the cap and Brat results in mRNA circularization and renders hb translationally inactive. Since the interaction between Brat and d4EHP does not involve the 4EHP binding motif we previously described (YxxxxxxLF), it is possible that d4EHP interacts with Brat through a bridging protein.
Our data support a model for the requirement for the 5 0 cap structure in regulation of endogenous hb mRNA. This is consistent with an earlier study that assessed translation of NRE-containing mRNAs after injection into Drosophila embryos and concluded that the cap structure is functionally significant [9] . In contrast, another study reported that Nos and Pum repressed the expression of an engineered transgene containing an internal ribosome entry site (IRES) and a hairpin loop designed to block cap-dependent translation [23] . These results were used to conclude that hb translational repression is cap independent. However, the phenotypic assay used in that study was indirect and the observed results could also be caused by RNA destabilization. Furthermore, Nos-dependent deadenylation was also shown to be important in establishing the Hb gradient [20] . It is difficult to reconcile all these data without concluding that multiple distinct posttranscriptional mechanisms regulate Hb expression, including two that require Nos. The novel d4EHP-dependent mechanism we defined appears important for repressing hb in more central regions of the embryo, while cap-independent regulation involving deadenylation of hb mRNA may predominate in more posterior regions of the embryo. We note that mutant forms of Brat that are abrogated for d4EHP interaction retain substantial (but not complete) activity in repressing hb, suggesting some redundancy between these two mechanisms. Analogous overlapping translational control mechanisms have recently been reported for Bruno, which represses Oskar (Osk) expression both through cap-dependent translational regulation and through packaging osk mRNA into translationally silent RNP complexes [24] . Our identification of a common inhibitory mechanism that regulates cad and hb mRNA translation simplifies our understanding of how the anterior-posterior axis is organized during early Drosophila embryogenesis. By regulating two classical maternal morphogenetic gradients, d4EHP plays a critical role in early Drosophila embryonic development. It is noteworthy that d4EHP is recruited to these mRNAs through different RNA binding proteins that presumably recognize different sequence elements. In the case of cad, d4EHP becomes associated by binding directly to Bcd, which in turn recognizes a defined 3 0 UTR element, the BBR [25, 26] . In the case of hb, Bcd binding is not involved in d4EHP recruitment and no element similar to the BBR is present. It remains uncertain whether the interaction between d4EHP and Brat is direct or indirect; because d4EHP and Brat are both uniformly distributed in early embryos [7, 10] , a nonuniformly distributed bridging protein mediating this interaction may be the basis of the spatially restricted requirement for d4EHP in hb repression. Since d4EHP and some of its interacting partners are evolutionarily conserved in higher eukaryotes and because cap-dependent translation regulation plays such an important role in eukaryotic gene expression [16] , we predict that 4EHP-dependent translational inhibitory mechanisms are widespread throughout the animal kingdom.
Experimental Procedures Plasmids
Cloning of d4EHP was previously described [10] . Brat cDNA (RE16276; Research Genetics) was obtained from the Berkeley Drosophila Genome Project [27] . All constructs reported herein were produced with the polymerase chain reaction (PCR). For brat, PCRamplified wild-type and mutant cDNAs were introduced into the pcDNA3-N-term-FLAG vector via EcoRV/NotI sites. For recombinant protein expression, Brat NHL domain and Nos C-term domain (Nos C-term) were subcloned into the pProEx-His vector by means of SalI/NotI and EcoRI/XhoI sites, respectively, and Pum RNA binding domain (Pum RNAB) into the pGEX 6p-1 vector by means of EcoRI/ SalI sites. NRE from hb mRNA, flanked by XbaI sites, was introduced into the 3 0 UTR of pcDNA3-rLuc-DApaI reporter vector. To create pCaSpeR4-nos promoter-Brat wild-type and mutant rescue vectors, Brat constructs were inserted into the pKS-nos promoter vector by means of NheI/NotI sites. Subsequently, a Kpn1/NotI cassette from pKS-nos promoter-Brat wild-type and mutant vectors were transferred into the pCaSpeR4 vector. All inserts were fully sequenced.
Recombinant Protein Purification E. coli BL21(DE3) transformed with the pProEx-Brat NHL domain, pProEx-Nos C-term, and pGEX-Pum RNAB constructs were used to produce His-Brat NHL domain, His-Nos C-term, and GST-Pum RNAB fusion proteins as previously described [10] . TALON Metal Affinity resin (BD Bioscience) and glutathione Sepharose 4B resin (Amersham Pharmacia) were used according to the manufacturers' instructions.
Brat Antibody and Western Blotting Analysis A Brat antibody (#3187) was raised in a New Zealand White rabbit injected with recombinant His-Brat NHL domain protein and used for western blotting (1:3000). Cell culture, coimmunoprecipitation, and western blotting were performed as previously described [10] .
Transgenic Rescue Experiment
Transgenic flies were generated by P element-mediated germline transformation of yw recipients with pCaSpeR-nos promoter-Brat wild-type and mutant rescue vectors. Transformed brat lines were crossed to the brat fs1 mutant and tested for the rescue of mutant phenotypes. pUASp-d4EHP transgenic lines [10] and antibody staining were performed as previously described [28] . Hb and Nos, Pum, and Brat immunostainings were visualized with Alexa Fluor 546 goat anti-rat IgG secondary and Alexa Fluor 488 goat anti-rabbit IgG secondary, respectively (1:500; Molecular Probes) with a confocal laser scanning microscope. Embryo images were analyzed for Hb gradient with Zeiss LSM data acquisition software.
In Vitro Transcription/Translation and Binding Assay pcDNA3-3HA-d4EHP [10] and pcDNA3-rLuc-DApaI-NRE vectors were linearized with ApaI and transcribed with T7 RNA polymerase (MBI). Nuclease-treated rabbit reticulocyte lysate (Promega) was incubated for 1 hr at 30 C with 300 ng of HA-d4EHP mRNA. Subsequently, the extract was supplemented with components of the NRE complex, and the experiments of Figure 4 were performed as previously described [7, 29] .
Image Analyses, Immunofluorescence Quantitation, and Data Analyses 0-to 2-hour-old embryos were immunostained with anti-Hb (1:10,000, a gift of P. Macdonald) and Alexa Fluor 546-conjugated secondary antibodies (Molecular Probes), and DNA was stained with DAPI. Images were captured with a Zeiss LSM510 confocal microscope. Quantitation of the fluorescence intensity was performed with Openlab (Improvision) by recording the intensity values within a nucleus-sized area sliding along the anterior-posterior axis. Multiple embryos (6-16) for each genotype were measured at 38-50 positions along the anterior-posterior axis for a total of more than 3000 data points. For each embryo, length was normalized (0% = anterior pole, 100% = posterior pole), and measured intensities were normalized by subtracting the intensity recorded at the posterior pole and dividing this value by the maximum intensity measured within the same embryo. Individual data points could have values below zero if the local signal intensity was less than that at the posterior pole. To generate the average curve, the data points for each genotype were grouped in 38 bins (corresponding to the smallest sample set). For each bin, values were averaged and the resulting 38 points constitute the average curve. 
Supplemental Data

